Clinical trial
ST36 Acupoint Injection With Anisodamine for Postoperative Nausea and Vomiting in Women Following Bariatric Surgery: A Multicentre, Randomised, Double-Blind Controlled Trial.
NCT05375721 is registered in ClinicalTrials.gov with The Second Hospital of Anhui Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ST36 Acupoint Injection With Anisodamine for Postoperative Nausea and Vomiting in Women Following Bariatric Surgery: A Multicentre, Randomised, Double-Blind Controlled Trial.
- Lead sponsor
- The Second Hospital of Anhui Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 23, 2022
- Completion date
- May 1, 2024
- Enrollment
- 300 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.